» Articles » PMID: 37035188

Diet-gut Microbial Interactions Influence Cancer Immunotherapy

Overview
Journal Front Oncol
Specialty Oncology
Date 2023 Apr 10
PMID 37035188
Authors
Affiliations
Soon will be listed here.
Abstract

The gut microbiome is involved in the absorption and metabolism of host nutrients and modulates the immune response, affecting the efficacy of immunotherapy for cancer. In patients receiving immunotherapy, appropriate modifications of gut microbiota are thought to improve therapeutic response. Of all the factors that influence the gut microbiota, diet is the most influential and modifiable. Healthy dietary patterns as well as some specific dietary components can help the growth of beneficial microbiota in the gut, thereby protecting against cancers and promoting human health. A growing number of researches have confirmed the positive effects of a diet-gut microbiota approach as an adjuvant therapy for cancer, but controversy remains. Here, we summarize the interactions between diet and gut microbes based on previous studies, and discuss the role of gut microbiota-based dietary strategies in tumor immunotherapy, with the potential mechanisms of actions also intensively discussed.

Citing Articles

Modulating tumor immunity using advanced microbiome therapeutics producing an indole metabolite.

Vaaben T, Lutzhoft D, Koulouktsis A, Dawoodi I, Stavnsbjerg C, Kvich L EMBO Rep. 2025; .

PMID: 40055466 DOI: 10.1038/s44319-025-00386-9.


Ketogenic diet and cancer: multidimensional exploration and research.

Wan S, Zhou X, Xie F, Zhou F, Zhang L Sci China Life Sci. 2025; .

PMID: 39821829 DOI: 10.1007/s11427-023-2637-2.


An exploratory study of a multi-species probiotic formulation and markers of health in a real-world oncological cohort in the time of covid.

Thomsen M, Vemuri R, Huygens F, Clarke S, Vitetta L Inflammopharmacology. 2024; 32(4):2317-2335.

PMID: 38926298 PMC: 11300539. DOI: 10.1007/s10787-024-01503-1.


Mechanism-guided fine-tuned microbiome potentiates anti-tumor immunity in HCC.

Liu T, Guo Y, Yanxia Liao , Liu J Front Immunol. 2024; 14:1333864.

PMID: 38169837 PMC: 10758498. DOI: 10.3389/fimmu.2023.1333864.


Circadian lifestyle determinants of immune checkpoint inhibitor efficacy.

Hughes B, Shanaz S, Ismail-Sutton S, Wreglesworth N, Subbe C, Innominato P Front Oncol. 2023; 13:1284089.

PMID: 38111535 PMC: 10727689. DOI: 10.3389/fonc.2023.1284089.

References
1.
Reuter S, Gupta S, Chaturvedi M, Aggarwal B . Oxidative stress, inflammation, and cancer: how are they linked?. Free Radic Biol Med. 2010; 49(11):1603-16. PMC: 2990475. DOI: 10.1016/j.freeradbiomed.2010.09.006. View

2.
Sannino D, Dobson A, Edwards K, Angert E, Buchon N . The Gut Microbiota Provisions Thiamine to Its Host. mBio. 2018; 9(2). PMC: 5845000. DOI: 10.1128/mBio.00155-18. View

3.
Shin S, Kim S, You H, Kim B, Kim A, Lee K . Drosophila microbiome modulates host developmental and metabolic homeostasis via insulin signaling. Science. 2011; 334(6056):670-4. DOI: 10.1126/science.1212782. View

4.
Ghiringhelli F, Rebe C, Hichami A, Delmas D . Immunomodulation and anti-inflammatory roles of polyphenols as anticancer agents. Anticancer Agents Med Chem. 2012; 12(8):852-73. DOI: 10.2174/187152012802650048. View

5.
De Almeida C, de Camargo M, Russo E, Amedei A . Role of diet and gut microbiota on colorectal cancer immunomodulation. World J Gastroenterol. 2019; 25(2):151-162. PMC: 6337022. DOI: 10.3748/wjg.v25.i2.151. View